Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
The American Journal of Medicine
|
December 18, 2003
Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease
Christopher J Lyon, Willa A Hsueh
ACS Nano
|
March 12, 2024
A Panorama of Extracellular Vesicle Applications: From Biomarker Detection to Therapeutics
Sumita Das, Christopher J Lyon, Tony Hu
Frontiers in Bioscience : a Journal and Virtual Library
|
February 10, 2004
Angiotensin II, PPAR-gamma and atherosclerosis
Ulrich Kintscher, Christopher J Lyon, Ronald E Law
Nature Reviews Bioengineering
|
April 17, 2023
CRISPR-based assays for low-resource settings
Zhen Huang, Christopher J Lyon, Tony Y Hu
Endocrinology
|
May 15, 2003
Minireview: adiposity, inflammation, and atherogenesis
Christopher J Lyon, Ronald E Law, Willa A Hsueh
Current Diabetes Reports
|
March 12, 2013
Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis
Anisha A Gupte, Christopher J Lyon, Willa A Hsueh
Journal of Materials Chemistry. B
|
May 30, 2020
Simulation-directed amplifiable nanoparticle enhanced quantitative scattering assay under low magnification dark field microscopy
Dali Sun, Li Yang, Christopher J Lyon, et al.
The American Journal of Medicine
|
July 6, 2004
Insulin resistance and the endothelium
Willa A Hsueh, Christopher J Lyon, Manuel J Quiñones
Current Diabetes Reports
|
July 22, 2005
Insulin resistance and the endothelium
Manuel J Quiñones, Susanne B Nicholas, Christopher J Lyon
Emerging Microbes & Infections
|
May 20, 2024
Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge
Hongyan Liao, Christopher J Lyon, Binwu Ying, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
The American Journal of Medicine
|
December 18, 2003
Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease
Christopher J Lyon, Willa A Hsueh
ACS Nano
|
March 12, 2024
A Panorama of Extracellular Vesicle Applications: From Biomarker Detection to Therapeutics
Sumita Das, Christopher J Lyon, Tony Hu
Frontiers in Bioscience : a Journal and Virtual Library
|
February 10, 2004
Angiotensin II, PPAR-gamma and atherosclerosis
Ulrich Kintscher, Christopher J Lyon, Ronald E Law
Nature Reviews Bioengineering
|
April 17, 2023
CRISPR-based assays for low-resource settings
Zhen Huang, Christopher J Lyon, Tony Y Hu
Endocrinology
|
May 15, 2003
Minireview: adiposity, inflammation, and atherogenesis
Christopher J Lyon, Ronald E Law, Willa A Hsueh
Current Diabetes Reports
|
March 12, 2013
Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis
Anisha A Gupte, Christopher J Lyon, Willa A Hsueh
Journal of Materials Chemistry. B
|
May 30, 2020
Simulation-directed amplifiable nanoparticle enhanced quantitative scattering assay under low magnification dark field microscopy
Dali Sun, Li Yang, Christopher J Lyon, et al.
The American Journal of Medicine
|
July 6, 2004
Insulin resistance and the endothelium
Willa A Hsueh, Christopher J Lyon, Manuel J Quiñones
Current Diabetes Reports
|
July 22, 2005
Insulin resistance and the endothelium
Manuel J Quiñones, Susanne B Nicholas, Christopher J Lyon
Emerging Microbes & Infections
|
May 20, 2024
Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge
Hongyan Liao, Christopher J Lyon, Binwu Ying, et al.
Page
of 9